Background-The optimal management of moderate (3+ on a scale of 0 to 4+) is
chemic mitral regurgitation (MR) remains controversial. Some advocate CABG
alone, whereas others favor concomitant mitral annuloplasty. To clarify the
optimal management of these patients, we evaluated the early impact of iso
lated CABG on moderate ischemic MR.
Methods and Results-Between January 1992 and August 1999, 136 patients (54%
male, mean age 70.5 years. mean New York Heart Association class 2.7, mean
ejection fraction 38.1%) with a preoperative diagnosis of moderate ischemi
c MR, without leaflet prolapse or pathology, underwent isolated CABG. Thirt
y-eight (28%) of 136 patients had intraoperative transesophageal echocardio
graphy (TEE) before CABG, and 68 (50%) had postoperative transthoracic echo
cardiography (TTE) within 6 weeks of surgery. The subgroups of patients und
ergoing intraoperative TEE and postoperative TTE had preoperative character
istics similar to the overall group. The 30-day operative mortality was 2.9
% (4/136). Intraoperative TEE downgraded the severity of MR to mild or less
(0 to 2+) in 89% (34/38). On postoperative TTE, 40% (27/68) continued to h
ave at least moderate MR (3 to 4+), 51% (35/68) improved somewhat to mild (
2+) MR, and only 9% (6/68) had resolution of their MR (0 to 1+). The mean p
reoperative, intraoperative, and postoperative MR grades were 3.0 +/-0.0, 1
.4 +/-1.0, and 2.3 +/-0.8, respectively (P <0.001).
Conclusions-CABG alone for moderate ischemic MR leaves many patients with s
ignificant residual MR and may not be the optimal therapy for most patients
. Intraoperative TEE may significantly underestimate the severity of ischem
ic MR. A preoperative diagnosis of moderate MR may warrant concomitant mitr
al annuloplasty.